COVID-19 Booster Vaccine Equity for Patients With Cancer

COVID-19 Booster Vaccine Equity for Patients With Cancer

COVID-19 has caused greater than 300 million documented infections worldwide including over 5 million confirmed deaths. Patients with cancer are particularly vulnerable due to a combination of disease and therapy-related effects. Available vaccines were highly effective against the original viral st...

Full description

Bibliographic Details
Main Authors:	Rahul N. Prasad, MD, MBA, Manali Patel, MD, MPH, MS, Joshua D. Palmer, MD
Format:	Article
Language:	English
Published:	Elsevier 2022-09-01
Series:	Advances in Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S245210942200046X

Similar Items

Acute vulvar ulcers and the COVID-19 booster vaccine
by: Michela Salusti-Simpson, BA, UVMMC, et al.
Published: (2022-08-01)

Delayed large local reactions to Moderna COVID-19 vaccine: A follow-up report after booster vaccination
by: Kimberly G. Blumenthal, MD, MSc, et al.
Published: (2022-09-01)

COVID-19 Vaccine Booster: To Boost or Not to Boost
by: Rahul Shekhar, et al.
Published: (2021-10-01)

Chronic urticaria after Moderna COVID-19 vaccine boosters: A case series
by: Chenin Ryan, MS, et al.
Published: (2024-03-01)

Global COVID-19 vaccine equity and the booster dose in low-resource countries: A decolonizing global health perspective
by: M. A. Rifat, et al.
Published: (2022-08-01)

Type I Brugada Pattern in a Febrile Patient Following COVID-19 Vaccination Booster
by: Robert Cacdac MD, et al.
Published: (2024-02-01)

Isolated breast parenchymal changes following COVID-19 vaccine booster
by: Emily Soeder, BS, et al.
Published: (2022-12-01)

Effect of COVID-19 vaccination and booster on maternal–fetal outcomes: a retrospective cohort study
by: Samantha N Piekos, PhD, et al.
Published: (2023-09-01)

Chronic spontaneous urticaria after COVID-19 primary vaccine series and boosters
by: Alexis Strahan, MSN, et al.
Published: (2022-07-01)

Booster Vaccination Strategies for “Living With COVID-19”
by: Jung Eun Kim, et al.
Published: (2022-06-01)

Mathematical analysis and simulation of COVID-19 model with booster dose vaccination strategy in Bangladesh
by: Anip Kumar Paul, et al.
Published: (2024-03-01)

COVID-19 vaccine boosters: The good, the bad, and the ugly
by: Rzymski, P, et al.
Published: (2021)

Global disparities in COVID-19 vaccine booster dose (VBD) acceptance and hesitancy: An updated narrative review
by: Debendra Nath Roy, et al.
Published: (2024-06-01)

Receptiveness of American adults to COVID-19 vaccine boosters: A survey analysis
by: Stephen R. Neely, et al.
Published: (2022-12-01)

Strategies and safety considerations of booster vaccination in COVID-19
by: Hanyan Meng, et al.
Published: (2022-06-01)

COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly
by: Piotr Rzymski, et al.
Published: (2021-11-01)

Sociodemographic and geographic disparities in COVID-19 booster vaccination in Nueces County, Texas, USA
by: Yuxia Huang, et al.
Published: (2024-03-01)

Breakthrough infections and acceptance of COVID-19 vaccine boosters: A survey analysis
by: Christina W. Stevens, et al.
Published: (2023-12-01)

Effectiveness of COVID-19 Vaccine Booster Shot Compared with Non-Booster: A Meta-Analysis
by: Yajuan Zhu, et al.
Published: (2022-08-01)

Cost Comparison From a Patient Perspective for Intracranial Stereotactic Radiation Therapy
by: Rahul N. Prasad, MD, MBA, et al.
Published: (2022-01-01)

An Assessment of the Bivalent Vaccine as a Second Booster for COVID-19
by: Sneh Lata Gupta, et al.
Published: (2022-12-01)

Evaluation of the Efficacy of COVID-19 Booster Vaccinations in Healthcare Personnel
by: Chung-Jong Kim, et al.
Published: (2022-10-01)

Importance of the COVID-19 Vaccine Booster Dose in Protection and Immunity
by: Alireza Abdollahi, et al.
Published: (2022-10-01)

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
by: Piotr Rzymski, et al.
Published: (2021-11-01)

Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?
by: Mildred A. Iro, et al.
Published: (2023-12-01)

Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?
by: Laura Ziegler, et al.
Published: (2023-12-01)

Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly
by: Camilla Mattiuzzi, et al.
Published: (2023-01-01)

Effectiveness of booster BCG vaccination in preventing Covid-19 infection
by: lradj Amirlak, et al.
Published: (2021-11-01)

Assessing the acceptability of COVID‐19 vaccine and its booster dose
by: Sawsan Mubarak, et al.
Published: (2023-09-01)

The pros and cons of the second booster dose of the COVID-19 vaccine
by: Ehsan Mostafavi
Published: (2022-08-01)

Antibody Response to COVID-19 Booster Vaccination in Healthcare Workers
by: Arianna Pani, et al.
Published: (2022-05-01)

Booster vaccinations protect shipboard personnel from COVID-19
by: Margaret Ryan, et al.
Published: (2022-06-01)

Crowdsourcing interventions to promote uptake of COVID-19 booster vaccines
by: Robert Böhm, et al.
Published: (2022-11-01)

Possible HSP reactivation post‐COVID‐19 vaccination and booster
by: Makoto Kondo, et al.
Published: (2021-10-01)

COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022
by: Peng-jun Lu, et al.
Published: (2023-01-01)

Willingness to pay for and willingness to vaccinate with the COVID-19 vaccine booster dose in China
by: Hui Jun Zhou, et al.
Published: (2022-09-01)

Opinion Polls and Antibody Response Dynamics of Vaccination with COVID-19 Booster Vaccines
by: Yufei Wu, et al.
Published: (2022-04-01)

Acceptance of COVID-19 vaccine booster dose among the people of Bangladesh: A cross-sectional study
by: Debendra Nath Roy, et al.
Published: (2023-11-01)

Will booster doses be required for serogroup B meningococcal vaccine?
by: McQuaid, F, et al.
Published: (2014)

COVID-19 vaccine equity in the Americas
by: The Lancet Regional Health– Americas
Published: (2022-01-01)